# Alex Luce

> Alex Luce is a seed investor at Creative Ventures backing Health Care and Biotechnology. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Creative Ventures](https://shizune.co/investors/profile/creative-ventures)
- Location: San Francisco Bay Area, United States
- Total investments: 7
- Last investment: Jan 2023
- Lead investor: 57%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alexluce/

Alex Luce is a seed investor at Creative Ventures in San Francisco Bay Area focused on Health Care and Biotechnology. Alex Luce is the General Partner at Creative Ventures.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Biotechnology | 2 | 29% |
| Energy Storage | 2 | 29% |
| Medical Device | 2 | 29% |
| Advanced Materials | 2 | 29% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 71% |
| Series A | 1 | 14% |
| Funding Round | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 2 | 29% |
| United States | 2 | 29% |
| Argentina | 1 | 14% |
| Australia | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Relectrify | Relectrify develops and supplies advanced battery control solutions, which increase the lifetime and reduce the cost of battery storage systems. The company's cell-level battery management and inverter technology is used in battery storage globally including for homes, industry and the grid, and is suitable for both second-life and newbatteries. |  |  | Jan 25, 2023 |  |
| Relectrify | Relectrify develops and supplies advanced battery control solutions, which increase the lifetime and reduce the cost of battery storage systems. The company's cell-level battery management and inverter technology is used in battery storage globally including for homes, industry and the grid, and is suitable for both second-life and newbatteries. | $9.3M | Series A | Jan 24, 2023 |  |
| OncoPrecision | We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives. | $3.3M | Seed | Aug 01, 2022 |  |
| Oncoustics AI | Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M | Seed | Jul 21, 2022 |  |
| VenoStent | VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. | $3M | Seed | Feb 23, 2021 |  |
| Terra CO2 Technologies | Terra CO2 Technologies is an industrial technology company that reduces material and logistics costs while reducing the environmental footprint in the cement and mining sectors. It develops innovative environmental technologies to tackle challenging environmental problems. It was founded in 2012 and employs a diverse group of engineers,scientists, and specialists to bring projects from the ideation stage to market. |  | Seed | Nov 01, 2020 |  |
| Sepion Technologies | Sepion is an advanced membrane company offering a platform suite of highly-tunable nanoscale membranes for multiple industrial markets. The company was founded in 2015 and is based in Emeryville, California, United States. |  | Seed |  |  |

7 of 7 investments shown.

## Co-investors
- [Clean Energy Finance Corporation](https://shizune.co/investors/profile/clean-energy-finance-corp) — VC Fund, 2 deals together
- [EDP Ventures](https://shizune.co/investors/profile/edp-ventures) — VC Fund, 2 deals together
- [Energy Innovation Capital](https://shizune.co/investors/profile/energy-innovation-capital) — VC Fund, 2 deals together
- [GS Futures](https://shizune.co/investors/profile/gs-futures) — VC Fund, 2 deals together
- [NOAB Ventures](https://shizune.co/investors/profile/noab-ventures) — VC Fund, 2 deals together
- [Toyota Ventures](https://shizune.co/investors/profile/toyota-ai-ventures) — VC Fund, 2 deals together

## About Creative Ventures

VC Fund · San Francisco, United States

Creative Ventures is a deep tech venture firm investing in early-stage companies solving humanity’s most critical crises. Led by a team of world-class experts, our deep tech acumen is informed by rigorous research, unmatched market understanding, and the dedication to lead our companies to success.Today’s problems can’t be solved by yesterday’ssolutions. Let’s get Creative.

5 contacts available at Creative Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Thanathon Sihawong | Analyst | https://shizune.co/investors/profile/dew-sihawong |
| Alex Luce | General Partner | https://shizune.co/investors/profile/alex-luce |
| Champ Suthipongchai | General Partner | https://shizune.co/investors/profile/champ-suthipongchai-2 |
| Daniel Lin | Operating Partner; Operating Partner | https://shizune.co/investors/profile/daniel-lin-5007 |
| James Wang | General Partner | https://shizune.co/investors/profile/james-wang-7 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Alex Luce invest in?

Alex Luce invests primarily in Health Care, Biotechnology and Energy Storage startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alex Luce last invest?

The most recent investment recorded for Alex Luce closed in Jan 2023. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co